Navigation Links
OLIGOMERIX Awarded NIH Grant to Develop Novel Biomarkers for Alzheimer's Disease
Date:2/25/2009

NEW YORK, Feb. 25 /PRNewswire/ -- OLIGOMERIX, Inc. today announced the receipt of a Small Business Innovation Research (SBIR) Phase I grant for $323,000 from the National Institute on Aging of the National Institutes of Health (NIH). The focus of the program is to develop novel biomarker assays for Alzheimer's disease (AD). Tau oligomers in complex with beta-amyloid or apolipoprotein E (apoE) proteins will be monitored in cerebrospinal fluid (CSF) and plasma from AD patients. The work will be done in collaboration with Drs. Lawrence S. Honig and Richard Mayeux at the Taub Institute for Research on Alzheimer's disease and the Aging Brain at Columbia University Medical Center (CUMC).

There is a critical unmet need for novel biomarkers for AD, both with respect to differential diagnosis of AD at first evaluation, and for monitoring disease progression. Presently, definitive diagnosis of AD can only be accomplished after death, through brain autopsy. There are no validated biomarkers from patient samples such as CSF or plasma that predict progression or regression of AD. OLIGOMERIX plans to evaluate novel AD biomarkers based on the paradigm of protein-protein interactions. This strategy may enable more specific diagnosis and disease monitoring, for better patient management.

"Our focus is to develop assays that can be used for drug discovery for AD," stated James Moe, Ph.D., MBA, President and CEO of OLIGOMERIX "Any validated assays developed under this program for disease staging or definitive diagnosis of AD will be potential out-licensing opportunities for the company."

ABOUT OLIGOMERIX

OLIGOMERIX, Inc. is a biopharmaceutical company founded in 2006 located at Audubon Biomedical Science and Technology Park, CUMC. The Company is developing a drug discovery platform that includes biomarker assays for discovering small molecule inhibitors of tau oligomer formation that are nove
'/>"/>

SOURCE OLIGOMERIX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Peter Zoller and Ignacio Cirac, awarded by the BBVA Foundation
2. Origin BioMed Awarded Red Herring Top 100 Global Company
3. Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone
4. Eurotech Catalyst Module Awarded to Allen Organ Company From Arrow Electronics
5. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
6. Probiotic Delivery Technology Awarded Third International Patent
7. Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
8. China Medicine Corporation Awarded GSP Certification
9. Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission
10. Transgenomic Awarded SBIR Grant to Support Development of SURVEYOR(R) Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
11. Yale professor T.P. Ma awarded the Connecticut Medal of Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Sept. 1, 2015 The American Brain Tumor ... for its Discovery Research Grant program. LOIs are due ... noon CDT. Discovery Grants are one-year, $50,000 ... potential to change current diagnostic or treatment paradigms for ... encourage novel research at its earliest stages, in the ...
(Date:9/1/2015)... 2015 Prostate cancer is the second ... men. One in seven men will be diagnosed ... are diagnosed annually. That said, not every diagnosis ... new technique, MRI Fusion Biopsy, to more accurately ... only the affected areas and monitoring areas ...
(Date:9/1/2015)... ... ... In her thought provoking debut novel ‘ Ebola Vaccine Wars ’ (eBookIt.com; ... an Ebola pandemic that is on the cusp of wiping out humanity. Venice introduces ... counterterrorism, and who continues to appear in this series of books by Venice. ...
(Date:9/1/2015)... Poway, CA (PRWEB) , ... September 01, 2015 ... ... Equine Cervical Facet joint disease. , Equine cervical facet joint problems can ... joints gradually enlarge, and can cause impingement of nerve roots or of the ...
Breaking Biology Technology:American Brain Tumor Association Seeks Innovative Concepts For Discovery Research Grants 2September Is Prostate Cancer Awareness Month 2September Is Prostate Cancer Awareness Month 3September Is Prostate Cancer Awareness Month 4Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 3VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease 2VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease 3
... 2011 EMG Laboratory ... the American Association of Neuromuscular & Electrodiagnostic Medicine,s ( ... Status. EMG Laboratory has provided advanced testing of ... Merrimack Valley and Cape Cod since 1997. Currently, it ...
... NEW YORK, Aug. 3, 2011 ... research report is available in its ... and Commercial Outlook 2011-2021 - discovering ... http://www.reportlinker.com/p0578545/Biomarkers-Technological-and-Commercial-Outlook-2011-2021---discovering-the-pharma-and-diagnostics-opportunities.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics ...
... 2011 Informex , the leading meeting ... today announced the introduction of a new conference, ... the Biopharmaceutical Evolution, to be hosted October 5-6th, ... will cover on-trend topics regarding the future of ...
Cached Biology Technology:EMG Laboratory Attains Prestigious National Accreditation for Clinical Excellence in Neuromuscular Diagnosis 2EMG Laboratory Attains Prestigious National Accreditation for Clinical Excellence in Neuromuscular Diagnosis 3Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 2Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 3Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 4Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 5Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 6Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 7Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 8Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 9Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 10Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 11Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 12Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 13Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 14New Conference Offers Solutions for Success in the Growing Biologics Market 2New Conference Offers Solutions for Success in the Growing Biologics Market 3
(Date:8/20/2015)... 20, 2015   Sensory, Inc ., a ... user experience and security of consumer electronics through ... that its TrulySecure™ is the first ... be FIDO Certified™. The FIDO (Fast ... the FIDO UAF (Universal Authentication Framework) 1.0 specifications, ...
(Date:8/18/2015)... , Aug. 18, 2015  Navitas ... key contributor to the Submission Content Management ... IRISS, a non-profit forum. Dedicated to the Implementation ... a neutral platform for industry, vendors, health ... information and work towards a standard method ...
(Date:8/12/2015)... 12, 2015   MedNet Solutions , an innovative ... of clinical research, is proud to announce that ... SaaS-based eClinical technology platform, has led the way to ... quarters of 2015.   Q2 2015 and Q1 2015 ... by contract value sold in the company,s 15 year ...
Breaking Biology News(10 mins):TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3MedNet Solutions Experiences Explosive Corporate Growth 2
... the Marine Biological Laboratory (MBL) in Woods Hole and ... the presence of the genetic material RNA in the ... proper cell division. , The findings, detailed June ... Proceedings of the National Academy of Sciences, present evidence ...
... cutting into their yields this year, said two Texas ... Station assistant research scientist and plant disease diagnostician, saw ... Plains Diagnostic Network lab this growing season, in addition ... the Panhandle. , Ninety-five percent of these samples were ...
... either preventing or promoting the cell death, a Queen's University ... principle that pharmacological inhibition of calpain may be used to ... such as in neuronal cells of Alzheimer's or Parkinson's patients, ... is clearly a very desirable outcome," says lead researcher Peter ...
Cached Biology News:RNA found in the cellular centrosome of surf clams 2More than drought affecting wheat yields 2Protein's role in regulating cell death sets direction for cancer research 2
XBP-1 (F-4)...
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
pETDuet-1 is designed for the coexpression of two target genes....
...
Biology Products: